Skip to content

The Healthcare News Network

Your daily guide to Medicare, insurance, medicines and staying well

Wednesday, October 14, 2026● Updated 6:00 AM ET
Staying Well

Patients report harms from popular unproven peptides

Published

Four people standing together with their arms around one another outdoors

Products like BPC-157 are pushed online for healing but have never been tested in human trials. Users describe migraines, eye pain and fatigue, and the FDA has not finished deciding whether to loosen limits on them.

Source: KFF Health News

This is a plain-language summary. Read the original source for full details.

More from the October 14, 2026 edition →